Biocon bets on weight-loss drugs as major growth engine for the business
Weight loss products have driven revenues in recent years for global giants like Novo Nordisk and Eli Lilly
Source: moneycontrol.com
Peter Bains News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Peter Bains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Peter Bains Today - Breaking & Trending Today
Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot
Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.
Source: indiatimes.com
Biocon leads India push into weight loss drugs as patents lapse
The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November.
Source: moneycontrol.com
Generic Weight Loss Drugs Boosted by UK Approval for Biocon
Biocon Ltd. is pivoting to anti-obesity therapies as patents for the blockbuster medications start to expire, unleashing a wave of generic supply for the global weight-loss market that’s expected to touch $100 billion by 2030.
Source: livemint.com
'Biocon looking at options to cut debt taken for Viatris' business buy'
"We are looking at a number of options to reduce that... I can say that you'll see the debt level coming down in the coming quarters," he said. Bains, who took over as group CEO of Biocon in September, declined to comment on specific debt reduction plans or timeline.
Source: indiatimes.com